Integrated Filing — IndAS



General information about company
Scrip Code 000000
NSE Symbol SRPL
MSEI Symbol NOTLISTED
ISIN INE008Z01012
Name of company SHREE RAM PROTEINS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 29-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 26-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Solvent Products
Start date and time of board meeting 29-May-2025   12:30:00
End date and time of board meeting 29-May-2025   14:28:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2024-08-05
Indicate Company website link for updated RPT policy of the Company https://www.shreeramproteins.com/public/media/report/file/direct_link-1879416668.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? Yes



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 0 0
Other income 240000 25540000
Total income 240000 25540000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 40052000 185720000
(d) Employee benefit expense 633000 2830000
(e) Finance costs 0 34049000
(f) Depreciation, depletion and amortisation expense 1673000 6693000
(f) Other Expenses
1 OtherExpense 1293000 6367000
Total other expenses 1293000 6367000
Total expenses 43651000 235659000
3 Total profit before exceptional items and tax -43411000 -210119000
4 Exceptional items 0 0
5 Total profit before tax -43411000 -210119000
6 Tax expense
7 Current tax 0 0
8 Deferred tax -205000 631000
9 Total tax expenses -205000 631000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations -43206000 -210750000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period -43206000 -210750000
17 Other comprehensive income net of taxes 0 0
18 Total Comprehensive Income for the period -43206000 -210750000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 214200000 214200000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 40587000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -0.2 -0.98
Diluted earnings (loss) per share from continuing operations -0.2 -0.98
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -0.2 -0.98
Diluted earnings (loss) per share from continuing and discontinued operations -0.2 -0.98
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 0
Capital work-in-progress 49000000
Investment property 0
Goodwill 0
Other intangible assets 0
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 0
Trade receivables, non-current
Loans, non-current 0
Other non-current financial assets
Total non-current financial assets 0
Deferred tax assets (net) 3536000
Other non-current assets 2414000
Total non-current assets 54950000
2 Current assets
Inventories 173228000
Current financial asset
Current investments 0
Trade receivables, current 236495000
Cash and cash equivalents 136000
Bank balance other than cash and cash equivalents 0
Loans, current 0
Other current financial assets 0
Total current financial assets 236631000
Current tax assets (net) 0
Other current assets 322464000
Total current assets 732323000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 787273000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 214200000
Other equity 40587000
Total equity attributable to owners of parent 254787000
Non controlling interest
Total equity 254787000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 133210000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 0
Total non-current financial liabilities 133210000
Provisions, non-current 905000
Deferred tax liabilities (net) 0
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 134115000
Current liabilities
Current financial liabilities
Borrowings, current 248157000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 103139000
Total Trade payable 103139000
Other current financial liabilities 6753000
Total current financial liabilities 358049000
Other current liabilities 2343000
Provisions, current 1624000
Current tax liabilities (Net) 36355000
Deferred government grants, Current 0
Total current liabilities 398371000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 532486000
Total equity and liabilites 787273000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax -210119000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0
Adjustments for decrease (increase) in inventories 185720000
Adjustments for decrease (increase) in trade receivables, current 700000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 569000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 3424000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 6693000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 207000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 0
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) 197313000
Net cash flows from (used in) operations -12806000
Dividends received 0
Interest paid -34049000
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 21243000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 0
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) investing activities 0
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 30692000
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 0
Interest paid 34049000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -18719000
Net cash flows from (used in) financing activities -22076000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -833000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -833000
Cash and cash equivalents cash flow statement at beginning of period 970000
Cash and cash equivalents cash flow statement at end of period 137000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Auditor's opinion Adverse opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s H B Kalaria & Associates Yes 31-Jul-2027


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income 240000 240000
2 Total Expenditure 43651000 43651000
3 Net Profit/(Loss) -43206000 -43206000
4 Earnings Per Share -0.2 -0.2
5 Total Assets 787273000 787273000
6 Total Liabilities 532486000 532486000
7 Net Worth 254787000 254787000


Audit qualification
Sr. Details of Audit Qualification Type of Audit Qualification Frequency of qualification For Audit Qualification(s) where the impact is quantified by the auditor For Audit Qualification(s) where the impact is not quantified by the auditor
Management's Views (i) Management's estimation on the impact of audit qualification (ii) If management is unable to estimate the impact, reasons for the same Auditors' Comments on (i) or (ii) above
1 Textual Information(1) Adverse opinion Whether appeared first time Textual Information(2) Textual Information(3) Textual Information(4) Textual Information(5)


Text Block
Textual Information(1) We draw your attention to the following matters: nMaterial uncertainty related to going concern status: We draw your attention to note. no. 7 of the financial statements where the Company has stated that the Company has defaulted in the repayment of its loans as well as payment of statutory dues (incl. CSR). The Company however continues to prepare its financial statements on a going-concern basis which is not in accordance with the provisions laid down in lnd-AS 1- Presentation of financial statements. n nWe would like to draw your attention to note no. 8 of financial results, where the Company has made disclosures regarding ongoing Corporate lnsolvency Resolution Process (CIRP) proceedings against the Company under The lnsolvency and Bankruptcy Code, 2016. These conditions, along with the matters nstated forth with indicate that a material uncertainty exists that may cast significant doubt on the Company's ability to cont;nue as a Boing concern. n nThe Company's management is responsible for carrying out the balance confirmation and reconciliations with various debtors, creditors, and advances. The Company has however not carried out any such balance confirmations and/or reconciliations with its debtors, creditors, and advances. n nThe Company has not carried out an inspection of its inventories for the period under review. We are, hence, unable to carry out a review of the position of its inventories as the balance sheet date. n nThe Company has not carried out physical inspection of its property, plant and equipment for the period under review. We are, hence, unable to carry out a review of the position of its fixed assets as at the balance sheet date. n nThe Company has not carried out an impairment assessment of its property, plant and equipment, inventories, advances, cash and bank balance and debtors. We are, hence, unable to provide an opinion on whether such balances reflect the true underlying economics of such balances.
Textual Information(2) Managements Response to Auditors Observations n n1. Material Uncertainty Related to Going Concern Status (Note No. 7): nThe Company acknowledges the default in repayment of certain loans and statutory dues, including CSR obligations, as mentioned in the financial statements. Despite the current financial constraints, the management has prepared the financial statements on a going concern basis, as it firmly believes that with the ongoing restructuring and recovery effortsincluding prospective investor interest and strategic business measuresthere exists a reasonable expectation that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. However, we acknowledge the uncertainty and are actively working with stakeholders to mitigate these concerns. n n2. Ongoing Corporate Insolvency Resolution Process (Note No. 8): nThe Company confirms that it is undergoing proceedings under the Corporate Insolvency Resolution Process (CIRP) as per the Insolvency and Bankruptcy Code, 2016. All relevant disclosures have been made in the financial statements. The outcome of the CIRP may have a significant impact on the future operations of the Company. Management, under the guidance of the Resolution Professional, is fully cooperating in the process and working toward a resolution in the best interest of all stakeholders. n n3. Balance Confirmations and Reconciliations: nThe Company acknowledges the delay in obtaining balance confirmations and carrying out reconciliations with its debtors, creditors, and advances. This was primarily due to operational limitations during the reporting period and resource constraints. The management has initiated a process to obtain these confirmations and perform reconciliations, and is committed to completing this exercise in a time-bound manner. n n4. Inventory Inspection: nDue to logistical and operational challenges during the reporting period, the Company was unable to conduct a physical inspection of inventories. Management is in the process of planning and executing a comprehensive inventory verification exercise, which will be completed in the upcoming quarter, subject to the directions and cooperation of the Resolution Professional. n n5. Physical Inspection of Property, Plant, and Equipment: nA detailed physical inspection of the Company's fixed assets could not be undertaken during the reporting period due to the ongoing financial and operational challenges. However, management is preparing to undertake such inspections and will ensure that a proper record and validation is maintained going forward. n n6. Impairment Assessment: nThe Company acknowledges that an impairment assessment of its assetsincluding property, plant and equipment, inventories, advances, cash and bank balances, and debtorswas not conducted during the reporting period due to constraints mentioned above. Management intends to carry out the necessary impairment testing in the forthcoming reporting period, based on updated financial data and operational performance, in alignment with Ind-AS requirements.
Textual Information(3) NA
Textual Information(4) NA
Textual Information(5) NA


Signatories detail
Name of CEO / Managing director LalitkumarChandulalVasoya
Name of CFO KRUTIL KISHORBHAI PARAKHIA
Name of audit committee chairman AKASH SURESHBHAI GAJERA
Name of statutory auditor M/s H B Kalaria & Associates
Name of other signatory, if any, with designation
Place Rajkot
Date 30-May-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 SHREE RAM PROTEINS LIMITED LALITKUMAR CHANDULAL VASOYA Chairman andnManaging Director Loan 4851000 NA 4851000 26461000 31103000
2 SHREE RAM PROTEINS LIMITED KRUTIL PARAKHIYA CFO Remuneration 520000 NA 520000 441000 861000
3 SHREE RAM PROTEINS LIMITED BHUPENDRA KANJIBHAI BHADANI CS Remuneration 243000 NA 243000 228000 527000
Total value of transaction during the reporting period 5614000





Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date 34635000
B Of the total amount outstanding, amount of default as on date 34635000
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date 0
B Of the total amount outstanding, amount of default as on date 0
3. Total financial indebtedness of the listed entity including short-term and long-term debt 0